Discover how we are developing navenibart (STAR-0215) as a preventative therapy for HAE with dosing once every 3 and 6 months: Our Science/STAR-0215
Connect with the US HAE Association (HAEA) here: www.haea.org
Connect with the International HAE Association (HAEi) here: www.haei.org
Contact Regan Sherman, our Executive Director of Patient Advocacy, here: advocacy@astriatx.com
Sign up to receive our newsletters here: Newsletters
SUBSCRIBE TO OUR NEWSLETTERS
I want to receive electronic communications from Astria Therapeutics (“Astria” or “we”) and I consent to the processing of the personal data I have provided for this purpose (which consent complies with applicable regulations, including Article 6(1)(a) of the EU General Data Protection Regulation).
To receive electronic communications from Astria, Astria uses the so-called double opt-in procedure. After you have consented to receive electronic communications from us on our Website, we will send you a message to the indicated email address asking for your confirmation. If you do not confirm that you would like to receive email communications, your request will automatically be deleted. You may at any time withdraw your consent to receive our electronic communications, in which case we will also delete your personal data connected to receiving our electronic communications. To declare that you wish to unsubscribe, you may use the respective link included in our communications or contact us at privacy@astriatx.com. Further details about our practices are available in our Website Privacy Notice.
Consent required.
The Astria Connection: HAE
The Astria Connection: AD
You are about to leave this website.
This link is provided as a convenience and for informational purposes only. It does not constitute an endorsement or an approval by Astria Therapeutics of any of the products, services or opinions of the corporation or organization or individual. Astria Therapeutics bears no responsibility for the accuracy, legality or content of this external site or for that of subsequent links. Please contact the external site for answers to questions regarding its content.
✕
